Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report.
Medtech investment hits 6-year high in Minnesota
Holaira lands $42M for lung denervation trial
Holaira said it raised a $42 million Series D round it plans to use for what it claims as the 1st randomized lung denervation trial with a sham control arm.
Minneapolis-based Holaira said the round was led by Vertex Venture Holdings and included 2 unnamed strategic investors, Windham Venture Partners and existing backers Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners and Versant Ventures.
Ex-KCI CEO Burzik dives into venture capital | Personnel Moves
Holaira raises $10M for lung device | Wall Street Beat
Medical device company Holaira said it drummed up $10 million, changed its name and moved its headquarters.
Formerly known as Innovative Pulmonary Solutions, Holaira said it plans to use the Series C round to develop its minimally invasive devices to treat obstructive lung disease. All of Holaira’s existing backers participated, namely Advanced Technology Ventures, Morgenthaler Ventures, Split Rock Partners, and Versant Ventures.
MassDevice Network
@MassDevice
LinkedIn
YouTube